AGM Proceedings: ₹10 Final Dividend Approved, All 9 Resolutions Passed
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Corona Remedies held its 22nd AGM on July 9, 2026 via video conferencing, with all 9 resolutions passed through remote e-voting. Key items: adoption of FY26 audited financials (standalone and consolidated), final dividend of ₹10 per share (100%) on face value ₹10 for FY 2025-26, reappointment of Mr. Nirav Mehta retiring by rotation, appointment of Walker Chandiok and Co LLP as statutory auditors and Dhara Patel as secretarial auditors, and reappointment of Dr. Kirtikumar Mehta as Non-Executive Chairman for 5 years. Commission and remuneration to directors were also approved.
Shareholders cleared the ₹10 final dividend for FY26 and reappointed key directors. Routine governance; voting results will be filed separately.